CD133 and CD13 have been widely used as LCSCs surface markers [5, 22], so CD13+CD133+ subpopulations were sorted from HCC cell lines and primary samples, followed by flow cytometry analysis (Supplementary Fig. S1, Fig. 1E). This evidence concerns the gene PROM1 and hepatocellular carcinoma.